Description: Although there is not definitive data on the actual number of persons who have a surgical ostomy, estimates for the United States are between 500,000 and 800,000 with a 3% annual growth rate since 2000. Persons who have ostomies differ from many other surgical patients, as they deal with complex physical, psychological, social and financial issues, even if the surgery is a complete success. Nurses and pharmacists are among those healthcare professionals who need access to current care guidelines, product information and educational information so as to offer an integrated approach to provide the person with a stoma the best possible outcome.
A Case of Connecting the Dots: Improving Diagnosis and Management of Fibromyalgia
Credit:
.1 CEU(s) 1.0 Credit Hour(s)
Accreditation:
ACCME, ACPE, NYSNA
Rating:
Not Currently Rated
Provider:
CME Outfitters, LLC
Release Date:
05/19/2010
Expiration Date:
05/19/2011
System Requirements:
Description: Pain is a common complaint in the primary care setting, and the standard of practice is to assess for the cause of the pain. Patients often present with painful symptoms of unknown etiology that cannot be defined by the degree of inflammation or damage to muscle tissue. Fibromyalgia affects an estimated 10 million people in the United States and is especially common in women. Many patients have additional symptoms including fatigue, headaches, irritable bowel syndrome, cognitive problems/memory lapses, sleep disturbances, anxiety, and depression. A recent CME Outfitters survey found that 62.8% of respondents were not confident or only somewhat confident in their ability to diagnose and manage fibromyalgia. In this neuroscienceCME Clinical Chart Review, the faculty will take participants through a patient case to demonstrate the complexities of appropriate assessment, diagnosis, and management of fibromyalgia, and provide insights and strategies for improving patient care and long-term outcomes.
Description: This is an update of the October 2007 AMCP Guide to Pharmaceutical Payment Methods which was created by the Academy of Managed Care Pharmacy Task Force on Pharmaceutical Payment Methods, in conjunction with the consulting firm of Tag & Associates, Inc. The update incorporates revisions by Tag & Associates, Inc. (Howard Tag, JD, and Elan Rubinstein, PharmD, MPH), Alexandria, VA. ACPE Universal Program Number: 233-000-09-028-H01-P
Description: One of the common misconceptions about ADHD is that it occurs only in children. The reality is that ADHD
can affect people of all ages. It is estimated that in the United States alone, nearly 8 million adults have ADHD.
While inattentiveness, impulsivity, and hyperactivity are the same hallmark features of both child and adult
ADHD, these symptoms often manifest quite differently in adults. For example, hyperactivity in the child may
be excessive running and climbing, while in the adult it is driving too fast. Impulsivity in the child can show up
as blurting out answers in class, whereas for the adult interrupting colleagues during a business meeting would
be likely. Recognition of the symptoms of ADHD that impact everyday life--at home, at work, and socially--is
critical. The good news is that adult ADHD is a treatable medical condition, when recognized and addressed
with an eye toward optimal management. Current data suggests that further continuing education and
professional development is warranted to address clinical practice gaps related to diagnosis and management
of ADHD in adults. In this neuroscienceCME Live and On Demand activity, expert faculty will explore best evidence to help clinicians achieve best practice as it relates to assessment, diagnosis, and management of adult ADHD.
Description: The abuse of OTC drugs is not a new problem but is one that has, along with prescription drug abuse, taken on new importance, especially among the adolescent population. The ease of obtaining the drugs, the low risk of detection, and the relatively poor perception of the risks involved by both teens and parents has contributed to this problem. Pharmacists need to be vigilant in addressing this situation and developing strategies to help reduce OTC drug abuse.
Description: Studies have shown that children with ADHD have higher rates of academic difficulties, social issues, and a number of comorbid psychiatric conditions compared to children without ADHD. These factors, and others, contribute to the high cost of care as well as diminished quality of life for children with ADHD. Applying the diagnostic criteria and unraveling the complexities of real-world patients can present a serious challenge to all clinicians. The symptom domains of ADHD--hyperactivity, impulsivity, and inattention--must often be diagnosed in the context of psychiatric comorbidities. The Multimodal Treatment Study of Children with ADHD (MTA) found that in a sample of 579 children, 31% had ADHD alone, 21% had oppositional symptoms, 12% had oppositional symptoms plus anxiety, 10% had anxiety symptoms, and 7% had comorbid conduct disorders. Careful clinical assessment of the child focusing on family history and longitudinal course of the disease is pivotal in order to develop appropriate treatment planning. A multimodal treatment approach that includes both pharmacologic and behavioral interventions is prudent. Ongoing monitoring at regular intervals utilizing structured data tools should be implemented to evaluate efficacy, tolerability, and compliance. In this evidence-based neuroscienceCME Live and On Demand activity, the expert faculty will explore the complex presentations of ADHD and provide strategies for the assessment, diagnosis, and individualized multimodal management of children and adolescents with ADHD.
Description: Despite advances in the management of cardiovascular disease, the spectrum of coronary artery disease presentations that collectively are recognized as acute coronary syndromes (ACS) continues to exact a tremendous toll of morbidity and mortality in the United States. ACS components include unstable angina (chest pain that does not result in myocardial necrosis) and acute myocardial infarction with or without ST-elevation. About 1.4 million cases of ACS occur annually in the United States, with associated 12-month rehospitalization costs estimated to be $222 million.
9/10 | Votes: 178 | 
View All
